The company’s IPO offered 8.8 million shares of common stock at a price of $15 per share to the public.
Piper Jaffray & Co., Barclays Capital and Wells Fargo Securities acted as joint book-running managers for the offering.
K2M is a global medical device company focused on designing, developing and commercializing complex spine technologies, techniques and minimally invasive procedures.
More Articles on Devices:
5 Key Results: LDR’s Mobi-C Artificial Disc Replacement vs. ACDF
FDA Clears AccelSPINE’s Next Generation Minimally Invasive Spine System
Global Medical Device Market to Grow at 6.2% Annually Until 2018
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.